Rajiv Radhakrishnan

Rajiv Radhakrishnan

Yale University

H-index: 33

North America-United States

About Rajiv Radhakrishnan

Rajiv Radhakrishnan, With an exceptional h-index of 33 and a recent h-index of 30 (since 2020), a distinguished researcher at Yale University, specializes in the field of Schizophrenia, cannabis, cognition.

His recent articles reflect a diverse array of research interests and contributions to the field:

37. The Structural Connectome Constrains in Vivo Synaptic Density Loss in Schizophrenia

Substance use and spine density: a systematic review and meta-analysis of preclinical studies

In Vivo Synaptic Density in Early Schizophrenia: Are There No Differences or Are They Too Small to Detect?

The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J

Impact of personal beliefs about medical cannabis on physician recommendation practices: Results of an international survey

Illness Phase as a Key Assessment and Intervention Window for Psychosis

Marijuana and madness

Cannabis and Psychosis Proneness

Rajiv Radhakrishnan Information

University

Position

School of Medicine

Citations(all)

4168

Citations(since 2020)

2825

Cited By

2251

hIndex(all)

33

hIndex(since 2020)

30

i10Index(all)

53

i10Index(since 2020)

48

Email

University Profile Page

Google Scholar

Rajiv Radhakrishnan Skills & Research Interests

Schizophrenia

cannabis

cognition

Top articles of Rajiv Radhakrishnan

37. The Structural Connectome Constrains in Vivo Synaptic Density Loss in Schizophrenia

Biological Psychiatry

2024/5/15

Substance use and spine density: a systematic review and meta-analysis of preclinical studies

2024/4/2

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

In Vivo Synaptic Density in Early Schizophrenia: Are There No Differences or Are They Too Small to Detect?

Biological Psychiatry

2024/3

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J

European Journal of Nuclear Medicine and Molecular Imaging

2024/3

Impact of personal beliefs about medical cannabis on physician recommendation practices: Results of an international survey

Asian journal of psychiatry

2023/7/1

Cannabis and Psychosis Proneness

Marijuana and Madness

2023/6/1

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

Role of psychedelics in treatment-resistant depression

2023/3/25

Manish Kumar Jha
Manish Kumar Jha

H-Index: 19

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

PET Biomarkers in Psychiatry

2023/12/1

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality

medRxiv

2023/11/27

Xin Zhou
Xin Zhou

H-Index: 6

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure

JAMA psychiatry

2023/9/1

Xin Zhou
Xin Zhou

H-Index: 6

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: Further support for an …

Psychological Medicine

2023/9

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

Lotta-Katrin Pries
Lotta-Katrin Pries

H-Index: 11

Characterization of an extreme phenotype of schizophrenia among women with homelessness

medRxiv

2023/8/5

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

International perspective on physician knowledge, attitude and practices related to medical cannabis

medRxiv

2023/7/27

Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C] OMAR PET

NeuroImage

2022/12/1

The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

European neuropsychopharmacology

2022/10/1

Impact of cannabis use, substance use disorders, and psychiatric diagnoses on COVID-19 outcomes: A retrospective cohort study

The Journal of Clinical Psychiatry

2022/8/29

Rajiv Radhakrishnan
Rajiv Radhakrishnan

H-Index: 23

See List of Professors in Rajiv Radhakrishnan University(Yale University)

Co-Authors

academic-engine